Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Statera BioPharma (STAB) Stock Price & Analysis

191 Followers

STAB Stock Chart & Stats

$0.00$0.00(100.00%)
At close: 9:30 AM EST
$0$2.5$5$7.5May 3May 4Apr 30May 4May 3
Day’s Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.03
Previous Close
$0.01
Volume
N/A
Average Volume (3M)
83.25K
Market Cap
$14.28K
Enterprise Value
$14.42T
Total Cash (Recent Filing)
$506.10K
Total Debt (Recent Filing)
$7.41M
Price to Earnings (P/E)
0.0
Beta
23.54
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Statera BioPharma News

STAB FAQ

What was Statera BioPharma’s price range in the past 12 months?
Statera BioPharma lowest stock price was $0.00 and its highest was $0.03 in the past 12 months.
What is Statera BioPharma’s market cap?
Statera BioPharma’s market cap is $14.28K.
When is Statera BioPharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Statera BioPharma’s earnings last quarter?
Statera BioPharma released its earnings results on Nov 14, 2022. The company reported -$0.067 earnings per share for the quarter.
Is Statera BioPharma overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Statera BioPharma pay dividends?
Statera BioPharma does not currently pay dividends.
What is Statera BioPharma’s EPS estimate?
Statera BioPharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Statera BioPharma have?
Statera BioPharma has 71,416,040 shares outstanding.
What happened to Statera BioPharma’s price movement after its last earnings report?
Statera BioPharma reported an EPS of -$0.067 in its last earnings report. Following the earnings report the stock price went same ―.
Which hedge fund is a major shareholder of Statera BioPharma?
Currently, no hedge funds are holding shares in STAB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology